Literature DB >> 24052023

Epigenetics: novel mechanism of pulmonary hypertension.

Jing-bin Huang1, Jian Liang, Xiao-fang Zhao, Wen-sen Wu, Fu Zhang.   

Abstract

INTRODUCTION: Epigenetics refers to changes in phenotype and gene expression that occur without alterations in DNA sequence. MicroRNAs are relatively recently discovered negative regulators of gene expression and act at the posttranscriptional level.
METHODS: This review summarizes epigenetic mechanisms of pulmonary hypertension, focusing on microRNAs related to pulmonary hypertension.
RESULTS: There are three major mechanisms of epigenetic regulation, including methylation of CpG islands, modification of histone proteins, and microRNAs. There may be an epigenetic component to pulmonary hypertension. These epigenetic abnormalities can be reversed therapeutically.
CONCLUSIONS: By better integrating network biology with evolving technologies in cell culture and in vivo experimentation, we will better understand epigenetic mechanisms of pulmonary hypertension and identify more diagnostic and therapeutic targets in pulmonary hypertension.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24052023     DOI: 10.1007/s00408-013-9505-1

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  87 in total

Review 1.  The evolution of gene regulation by transcription factors and microRNAs.

Authors:  Kevin Chen; Nikolaus Rajewsky
Journal:  Nat Rev Genet       Date:  2007-02       Impact factor: 53.242

Review 2.  Phenotypic plasticity and the epigenetics of human disease.

Authors:  Andrew P Feinberg
Journal:  Nature       Date:  2007-05-24       Impact factor: 49.962

Review 3.  Novel strategy for treatment of pulmonary arterial hypertension: enhancement of apoptosis.

Authors:  Jing-bin Huang; Ying-long Liu; Pei-wu Sun; Xiao-dong Lv; Kong Bo; Xiang-ming Fan
Journal:  Lung       Date:  2010-03-06       Impact factor: 2.584

4.  Bone morphogenetic protein receptor type II C-terminus interacts with c-Src: implication for a role in pulmonary arterial hypertension.

Authors:  Wai K P Wong; James A Knowles; Jane H Morse
Journal:  Am J Respir Cell Mol Biol       Date:  2005-07-07       Impact factor: 6.914

5.  A role for miR-145 in pulmonary arterial hypertension: evidence from mouse models and patient samples.

Authors:  Paola Caruso; Yvonne Dempsie; Hannah C Stevens; Robert A McDonald; Lu Long; Ruifang Lu; Kevin White; Kirsty M Mair; John D McClure; Mark Southwood; Paul Upton; Mei Xin; Eva van Rooij; Eric N Olson; Nicholas W Morrell; Margaret R MacLean; Andrew H Baker
Journal:  Circ Res       Date:  2012-06-19       Impact factor: 17.367

6.  Clinical and pathologic comparison of simple left-to-right shunt congenital heart disease and transposition of the great arteries with ventricular septal defect.

Authors:  Jing-bin Huang; Jian Liang; Ming Du
Journal:  Heart Surg Forum       Date:  2012-04       Impact factor: 0.676

7.  Comprehensive methylome map of lineage commitment from haematopoietic progenitors.

Authors:  Hong Ji; Lauren I R Ehrlich; Jun Seita; Peter Murakami; Akiko Doi; Paul Lindau; Hwajin Lee; Martin J Aryee; Rafael A Irizarry; Kitai Kim; Derrick J Rossi; Matthew A Inlay; Thomas Serwold; Holger Karsunky; Lena Ho; George Q Daley; Irving L Weissman; Andrew P Feinberg
Journal:  Nature       Date:  2010-08-15       Impact factor: 49.962

8.  Interleukin-6 modulates the expression of the bone morphogenic protein receptor type II through a novel STAT3-microRNA cluster 17/92 pathway.

Authors:  Matthias Brock; Michelle Trenkmann; Renate E Gay; Beat A Michel; Steffen Gay; Manuel Fischler; Silvia Ulrich; Rudolf Speich; Lars C Huber
Journal:  Circ Res       Date:  2009-04-23       Impact factor: 17.367

9.  Mir-206 regulates pulmonary artery smooth muscle cell proliferation and differentiation.

Authors:  Samuel Jalali; Gurukumar K Ramanathan; Prasanna Tamarapu Parthasarathy; Salman Aljubran; Lakshmi Galam; Asfiya Yunus; Sara Garcia; Ruan R Cox; Richard F Lockey; Narasaiah Kolliputi
Journal:  PLoS One       Date:  2012-10-10       Impact factor: 3.240

10.  Antagomir-mediated silencing of endothelial cell specific microRNA-126 impairs ischemia-induced angiogenesis.

Authors:  Coen van Solingen; Leonard Seghers; Roel Bijkerk; Jacques M G J Duijs; Marko K Roeten; Annemarie M van Oeveren-Rietdijk; Hans J Baelde; Matthieu Monge; Joost B Vos; Hetty C de Boer; Paul H A Quax; Ton J Rabelink; Anton Jan van Zonneveld
Journal:  J Cell Mol Med       Date:  2009-08       Impact factor: 5.310

View more
  11 in total

1.  Inhibition of histone deacetylase reduces transcription of NADPH oxidases and ROS production and ameliorates pulmonary arterial hypertension.

Authors:  Feng Chen; Xueyi Li; Emily Aquadro; Stephen Haigh; Jiliang Zhou; David W Stepp; Neal L Weintraub; Scott A Barman; David J R Fulton
Journal:  Free Radic Biol Med       Date:  2016-08-03       Impact factor: 7.376

Review 2.  Role of epigenetics in pulmonary hypertension.

Authors:  Tara V Saco; Prasanna Tamarapu Parthasarathy; Young Cho; Richard F Lockey; Narasaiah Kolliputi
Journal:  Am J Physiol Cell Physiol       Date:  2014-04-09       Impact factor: 4.249

3.  Clinical comparative analysis of histidine-tryptophan-ketoglutarate solution and St. Thomas crystalloid cardioplegia: A 12-year study from a single institution.

Authors:  Ying-Zhong Lin; Jing-Bin Huang; Xiang-Wei Li; Xian-Ming Tang; Wei-Jun Lu; Zhao-Ke Wen; Jian Liang; Dian-Yuan Li; Hao Wang
Journal:  Exp Ther Med       Date:  2017-07-19       Impact factor: 2.447

Review 4.  MicroRNA: A new therapeutic strategy for cardiovascular diseases.

Authors:  Saheli Samanta; Sathyamoorthy Balasubramanian; Sheeja Rajasingh; Urmi Patel; Anuradha Dhanasekaran; Buddhadeb Dawn; Johnson Rajasingh
Journal:  Trends Cardiovasc Med       Date:  2016-03-03       Impact factor: 6.677

Review 5.  Epigenetics of Mucus Hypersecretion in Chronic Respiratory Diseases.

Authors:  Tara V Saco; Mason T Breitzig; Richard F Lockey; Narasaiah Kolliputi
Journal:  Am J Respir Cell Mol Biol       Date:  2018-03       Impact factor: 6.914

Review 6.  South Asian Cardiovascular Disease & Cancer Risk: Genetics & Pathophysiology.

Authors:  Latha Palaniappan; Arun Garg; Enas Enas; Henrietta Lewis; Sehrish Bari; Martha Gulati; Cristina Flores; Ashish Mathur; Cesar Molina; Jagat Narula; Shahid Rahman; Jennifer Leng; Francesca Gany
Journal:  J Community Health       Date:  2018-12

7.  Epigenetics, inflammation and metabolism in right heart failure associated with pulmonary hypertension.

Authors:  Nolwenn Samson; Roxane Paulin
Journal:  Pulm Circ       Date:  2017-06-19       Impact factor: 3.017

8.  Reversal of MicroRNA Dysregulation in an Animal Model of Pulmonary Hypertension.

Authors:  Igor B Gubrij; Amanda K Pangle; Li Pang; Larry G Johnson
Journal:  PLoS One       Date:  2016-01-27       Impact factor: 3.240

Review 9.  Insights on the epigenetic mechanisms underlying pulmonary arterial hypertension.

Authors:  R C P Luna; Y de Oliveira; J V C Lisboa; T R Chaves; T A M de Araújo; E E de Sousa; M Miranda Neto; L Pirola; V A Braga; J L de Brito Alves
Journal:  Braz J Med Biol Res       Date:  2018-10-18       Impact factor: 2.590

Review 10.  Systems Medicine for Lung Diseases: Phenotypes and Precision Medicine in Cancer, Infection, and Allergy.

Authors:  Bernd Schmeck; Wilhelm Bertrams; Xin Lai; Julio Vera
Journal:  Methods Mol Biol       Date:  2016
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.